The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Reading miRNAs for Clinical Meaning
Single miRNAs Don’t Say Much, but They May Become Eloquent Biomarkers if We Take Their Testimony in Context
Sorting Out the CRISPR Patent Case
Sounds of Science Podcast
For full access to this article login to GEN Select now.
Next Generation Sequencing of Microbiomes
Molzym has been committed to innovative solutions for biological research and diagnosis of infectious diseases The efforts are particularly focused on new processes enabling and facilitating the molecular diagnosis and next generation sequencing (NGS) of diseases caused by bacteria and fungi This overview discusses pre-analytical problems and solutions contributed by new tools for nucleic acid extraction and PCR amplification on microbiome research...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.